announced the online publication of safety data from patients with Ataxia-Telangiectasia (A-T) treated with EryDex for a minimum of 24 months in Frontiers in Neurology. “A-T is a rare pediatric ...
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder that primarily affects male carriers of the FMR1 gene premutation, characterized by an expansion of CGG ...
Medtel announces the appointment of Dr. Kevin Most as Senior Advisor. With over 30 years of healthcare leadership, including 17 years as CMO at Northwestern Medicine Central DuPage Hospital, Dr. Most ...
In this paper the authors have identified two new participants in the damage-response pathway, using cells from patients with ataxia-telangiectasia [AT], a disease characterized by hypersensitivity to ...
Short for ataxia telangiectasia and Rad3-related kinase ... Another woman with advanced ovarian cancer whose disease had come back after treatment with a drug blocking PARP, another key DNA ...
Publicis Health has made key leadership appointments at Digitas Health, reaffirming the agency's position as a leader in the healthcare marketing industry and underscoring its commitment to creativity ...
What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...
June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...
“We have the first device to treat macular telangiectasia type 2, which has been through the clinical trial program, and the long-term results up to 9 years find that it is still relatively well ...